We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The developers will not receive any royalties on sales for as long as the World Health Organization considers COVID-19 a public health emergency. Read More
In oral arguments held Wednesday, Sanofi urged a federal appeals court to reconsider its complaint against Mylan (now Viatris) over allegations the latter engaged in anticompetitive practices to maintain its EpiPen monopoly. Read More
Thanks to a recent legal win for Merck, companies may have an easier time getting insurance coverage for damage incurred from nation-state-backed malware attacks. Read More
The Florida suit against Endo was one of the thousands filed by states, counties, cities and other municipal bodies seeking to hold drugmakers, distributors and pharmacy chains accountable for the epidemic. Read More
Pfizer has partnered with Beam Therapeutics to develop messenger RNA (mRNA)-based therapies for rare genetic diseases — a move to expand its portfolio of mRNA technology used to produce its landmark COVID-19 vaccine. Read More
RSS
